NIH Received $710 Million in Royalties From Drugmakers: Report; AI Insiders Warn of ‘Serious Risks’ Posed by the Tech | Business Matters Full Broadcast (June 4)

Royalty payments from drug companies to the National Institutes of Health (NIH) jumped following the COVID-19 pandemic in 2021, according to a new report from nonprofit government watchdog “OpenTheBooks.com.” It says that in 2022 and 2023, pharmaceutical and health care companies paid the NIH over $710 million in third-party roy...